Prednisone Market size is estimated to cross USD 9 billion by the end of 2036, expanding around 5% CAGR during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of prednisone was over USD 6 billion. The major element to influence the market expansion is the surge in the prevalence of skin disease. According to the World Health Organization, it has been estimated that 1.8 billion people worldwide suffer from skin disorders at any given moment. Skin infections, which may be caused by bacteria, viruses, fungi, or parasites, are the most common cause of illness in tropical and low-resource environments.
As a result, there have been growing initiatives such as the launch of new prednisone medication and spreading awareness among people for the same by the government in such an environment to tackle the issue of skin disease. This is since it is estimated that skin disease might also further increase the prevalence of death. Therefore, the market demand for prednisone is set to grow over the coming years.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
~5% |
Base Year Market Size (2023) |
~ USD 6 Billion |
Forecast Year Market Size (2036) |
~ USD 9 Billion |
Regional Scope |
|
Disease (Rheumatology Indications, Skin Allergies, Endocrinology, Gastroenterology, Acute Respiratory Disease, Others)
The skin allergies segment is projected to hold 40% share of the global prednisone market by 2036. There has been a growing prevalence of acne all across the globe. A lot of people have acne, and it affects about 8% of the global population, according to research estimates. Additionally, cases of acne are highly seen among teenagers. This prevalent skin condition, which affects over 84% of teenagers, is characterized by clogged pores (whiteheads and blackheads), uncomfortable pimples, and occasionally hard, deep lumps on the face, neck, shoulders, chest, back, and upper arms. Hence, with the growing population of teenagers, the segment is set to have significant growth over the forecast period.
Application (Hospital, Clinic, Recovery Center)
Prednisone market from the hospital segment is poised to generate the highest revenue share of about 50% over the coming years. This could be owing to the growing investment made in the healthcare sector. Additionally, the number of patients getting admitted to hospitals is also surging. Hospitalized individuals who have a wide range of serious illnesses, such as those with neurological, pulmonary, and cardiovascular diseases, might benefit from steroids. Hospitals provide care for a wide variety of illnesses through dermatology medical devices. Hospitalist physicians typically have a focus on internal medicine, pediatrics, or family practice. They have the resources to handle complex medical problems as well as the knowledge to assist with routine ones. Moreover, there has been an increase in advancement in hospitals and a wide array of medicines are available here.
Our in-depth analysis of the global prednisone market includes the following segments:
Disease |
|
Application |
|
North American Market Forecasts
The North America prednisone market is set to gather the highest share of about 35% over the forecast period. This growth could be influenced by the rising prevalence of asthma in this region. Asthma affects approximately 7% of Americans. About 19 million of them over 25 million are adults, while 6.1 million are children. Although illness prevalence varies and the majority of disease-related deaths take place in low-income nations, asthma remains a serious public health concern throughout the Americas. Additionally, globally, especially in the Americas, obesity has been linked with higher severity of asthma and asthma in children and adults. Some research indicates that obesity is more strongly associated with asthma outcomes in females. Leptin levels in cord blood are linked to asthma in Chilean infants born to obese mothers, and maternal obesity and diet have also been linked to asthma in children. All these factors which is boosting the prevalence of asthma are also predicted to dominate the market demand for prednisone in this region.
APAC Market Analysis
The prednisone market in Asia Pacific is set to have notable growth during the forecast period. This growth of the market is predicted to rise on account of the lack of physical activity which has further given rise to the number of diseases in this region. Additionally, there has been a rise in the prevalence of kidney disorders in this region. In the eastern, southern, and southeast parts of Asia, up to 434.3 million people are affected by chronic kidney disease (CKD), with China and India accounting for the majority of cases (up to 299.9 million). Therefore, the growth of the market in this region is projected to flourish.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?